<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Blood and Cancer</title>
<title_fa></title_fa>
<short_title>Iranian Journal of Blood and Cancer</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijbc.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-4595</journal_id_issn>
<journal_id_issn_online>2008-4609</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/ijbc</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>2008-4595</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1403</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2024</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<volume>16</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Molecular Pathways of Gliomas Involving RNA-Binding Protein Dynamics</title>
	<subject_fa>Adults Hematology &amp; Oncology</subject_fa>
	<subject>Adults Hematology &amp; Oncology</subject>
	<content_type_fa>مقاله مروری</content_type_fa>
	<content_type>Review Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;line-height:2;&quot;&gt;Gliomas are malignant brain tumors with complicated molecular changes contributing to their aggressiveness and limited treatment choices. RNA-binding proteins are important in post-transcriptional regulation, altering gene expression and impacting glioma formation. In this review article, we will deliberate different molecular pathways of gliomas in which RNA-binding proteins are involved. Studies reveal that a few years ago, RNA-binding proteins had a causative effect on various cancer types such as leukemia, glioblastoma, intestinal, renal, etc. RNA-binding proteins have surfaced as key players in regulating post-transcriptional processes. So, we will discuss in this article Maintaining Glioma Cells Growth, RNA-binding proteins mutations, interacting with deubiquitinating enzymes, RBP Methylation Activates Oncogenic Pathways and RNA-binding proteins in glioma subtypes, highlighting their role in tumorigenesis, invasion, angiogenesis, and therapeutic resistance.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>RNA-binding proteins, Gliomas, post-transcriptional regulation, Oncogenetic pathways, RBP Methylation</keyword>
	<start_page>70</start_page>
	<end_page>83</end_page>
	<web_url>http://ijbc.ir/browse.php?a_code=A-10-1068-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Saman</first_name>
	<middle_name></middle_name>
	<last_name>Batool</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Samanbatool450@gmail.com</email>
	<code>100319475328460011123</code>
	<orcid>100319475328460011123</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Gomal Centre of Biochemistry and Biotechnology, Gomal University, D.I.Khan, Pakistan.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hamza</first_name>
	<middle_name></middle_name>
	<last_name>Tanveer</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hamzatanveer.riphah@gmail.com</email>
	<code>100319475328460011124</code>
	<orcid>100319475328460011124</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Faisal</first_name>
	<middle_name></middle_name>
	<last_name>Naeem</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>faisalbandeshah@gmail.com</email>
	<code>100319475328460011125</code>
	<orcid>100319475328460011125</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department OF Forensic Medicine and Toxicology, Post Graduate Medical Institute, Lahore, Pakistan</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Asma</first_name>
	<middle_name></middle_name>
	<last_name>Sarfaraz</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>asmasarfraz.0237.scps@gmail.com</email>
	<code>100319475328460011126</code>
	<orcid>100319475328460011126</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Shifa Tameer-e-Millat University of Pharmaceutical Sciences, Islamabad, Pakistan</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
